nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—Phenylephrine—Orciprenaline—asthma	0.158	0.325	CrCrCtD
Tapentadol—Phenylephrine—Terbutaline—asthma	0.137	0.282	CrCrCtD
Tapentadol—Phenylephrine—Isoprenaline—asthma	0.0997	0.206	CrCrCtD
Tapentadol—Phenylephrine—Salbutamol—asthma	0.0905	0.187	CrCrCtD
Tapentadol—UGT1A9—Zileuton—asthma	0.0815	0.262	CbGbCtD
Tapentadol—CYP2D6—Ciclesonide—asthma	0.015	0.0483	CbGbCtD
Tapentadol—CYP2C19—Zafirlukast—asthma	0.0144	0.0464	CbGbCtD
Tapentadol—CYP2C19—Arformoterol—asthma	0.0139	0.0448	CbGbCtD
Tapentadol—CYP2C19—Formoterol—asthma	0.0139	0.0448	CbGbCtD
Tapentadol—CYP2C9—Zileuton—asthma	0.0136	0.0438	CbGbCtD
Tapentadol—CYP2D6—Ipratropium bromide—asthma	0.0125	0.0401	CbGbCtD
Tapentadol—CYP2C9—Zafirlukast—asthma	0.012	0.0386	CbGbCtD
Tapentadol—CYP2C9—Arformoterol—asthma	0.0116	0.0373	CbGbCtD
Tapentadol—CYP2C9—Formoterol—asthma	0.0116	0.0373	CbGbCtD
Tapentadol—CYP2D6—Zafirlukast—asthma	0.011	0.0353	CbGbCtD
Tapentadol—CYP2D6—Formoterol—asthma	0.0106	0.0341	CbGbCtD
Tapentadol—CYP2D6—Arformoterol—asthma	0.0106	0.0341	CbGbCtD
Tapentadol—CYP2C19—Loratadine—asthma	0.0106	0.034	CbGbCtD
Tapentadol—CYP2D6—Tiotropium—asthma	0.00944	0.0304	CbGbCtD
Tapentadol—CYP2C9—Theophylline—asthma	0.00926	0.0298	CbGbCtD
Tapentadol—CYP2C9—Montelukast—asthma	0.00878	0.0282	CbGbCtD
Tapentadol—CYP2C9—Loratadine—asthma	0.00878	0.0282	CbGbCtD
Tapentadol—CYP2D6—Theophylline—asthma	0.00847	0.0272	CbGbCtD
Tapentadol—CYP2D6—Loratadine—asthma	0.00803	0.0258	CbGbCtD
Tapentadol—CYP2C19—Prednisone—asthma	0.00585	0.0188	CbGbCtD
Tapentadol—CYP2C19—Dexamethasone—asthma	0.00365	0.0117	CbGbCtD
Tapentadol—CYP2C9—Dexamethasone—asthma	0.00304	0.00977	CbGbCtD
Tapentadol—CYP2D6—Dexamethasone—asthma	0.00278	0.00893	CbGbCtD
Tapentadol—HTR3A—vagus nerve—asthma	0.00132	0.44	CbGeAlD
Tapentadol—SLC6A2—autonomic nervous system—asthma	0.000613	0.205	CbGeAlD
Tapentadol—HTR3A—respiratory system—asthma	0.000235	0.0786	CbGeAlD
Tapentadol—SLC6A4—respiratory system—asthma	0.000179	0.06	CbGeAlD
Tapentadol—SLC6A2—respiratory system—asthma	0.000158	0.0528	CbGeAlD
Tapentadol—HTR3A—lung—asthma	0.000125	0.0418	CbGeAlD
Tapentadol—SLC6A2—adrenal gland—asthma	9.55e-05	0.032	CbGeAlD
Tapentadol—SLC6A4—lung—asthma	9.51e-05	0.0318	CbGeAlD
Tapentadol—CYP2C9—cardiovascular system—asthma	8.81e-05	0.0295	CbGeAlD
Tapentadol—SLC6A2—lung—asthma	8.37e-05	0.028	CbGeAlD
Tapentadol—Visual impairment—Dexamethasone—asthma	4.94e-05	0.000363	CcSEcCtD
Tapentadol—Visual impairment—Betamethasone—asthma	4.94e-05	0.000363	CcSEcCtD
Tapentadol—Mental disorder—Methylprednisolone—asthma	4.94e-05	0.000362	CcSEcCtD
Tapentadol—Malnutrition—Methylprednisolone—asthma	4.9e-05	0.00036	CcSEcCtD
Tapentadol—Angioedema—Prednisolone—asthma	4.88e-05	0.000359	CcSEcCtD
Tapentadol—Dizziness—Budesonide—asthma	4.87e-05	0.000358	CcSEcCtD
Tapentadol—Vomiting—Salbutamol—asthma	4.84e-05	0.000355	CcSEcCtD
Tapentadol—Vertigo—Prednisolone—asthma	4.8e-05	0.000353	CcSEcCtD
Tapentadol—Rash—Salbutamol—asthma	4.8e-05	0.000352	CcSEcCtD
Tapentadol—Syncope—Prednisolone—asthma	4.79e-05	0.000352	CcSEcCtD
Tapentadol—Dermatitis—Salbutamol—asthma	4.79e-05	0.000352	CcSEcCtD
Tapentadol—Eye disorder—Betamethasone—asthma	4.79e-05	0.000352	CcSEcCtD
Tapentadol—Eye disorder—Dexamethasone—asthma	4.79e-05	0.000352	CcSEcCtD
Tapentadol—Nausea—Arformoterol—asthma	4.78e-05	0.000351	CcSEcCtD
Tapentadol—Nausea—Formoterol—asthma	4.78e-05	0.000351	CcSEcCtD
Tapentadol—Angioedema—Hydrocortisone—asthma	4.77e-05	0.00035	CcSEcCtD
Tapentadol—Headache—Salbutamol—asthma	4.77e-05	0.00035	CcSEcCtD
Tapentadol—Loss of consciousness—Prednisolone—asthma	4.7e-05	0.000345	CcSEcCtD
Tapentadol—Vertigo—Hydrocortisone—asthma	4.69e-05	0.000344	CcSEcCtD
Tapentadol—Nausea—Montelukast—asthma	4.69e-05	0.000344	CcSEcCtD
Tapentadol—Vomiting—Budesonide—asthma	4.68e-05	0.000344	CcSEcCtD
Tapentadol—Syncope—Hydrocortisone—asthma	4.68e-05	0.000344	CcSEcCtD
Tapentadol—Angiopathy—Dexamethasone—asthma	4.65e-05	0.000341	CcSEcCtD
Tapentadol—Angiopathy—Betamethasone—asthma	4.65e-05	0.000341	CcSEcCtD
Tapentadol—Rash—Budesonide—asthma	4.65e-05	0.000341	CcSEcCtD
Tapentadol—Dermatitis—Budesonide—asthma	4.64e-05	0.000341	CcSEcCtD
Tapentadol—Convulsion—Prednisolone—asthma	4.63e-05	0.00034	CcSEcCtD
Tapentadol—Headache—Budesonide—asthma	4.62e-05	0.000339	CcSEcCtD
Tapentadol—Loss of consciousness—Hydrocortisone—asthma	4.59e-05	0.000337	CcSEcCtD
Tapentadol—Bradycardia—Prednisone—asthma	4.54e-05	0.000334	CcSEcCtD
Tapentadol—Convulsion—Hydrocortisone—asthma	4.52e-05	0.000332	CcSEcCtD
Tapentadol—Nausea—Salbutamol—asthma	4.52e-05	0.000332	CcSEcCtD
Tapentadol—Angioedema—Triamcinolone—asthma	4.49e-05	0.00033	CcSEcCtD
Tapentadol—Angioedema—Methylprednisolone—asthma	4.48e-05	0.000329	CcSEcCtD
Tapentadol—Hallucination—Prednisone—asthma	4.44e-05	0.000326	CcSEcCtD
Tapentadol—Anxiety—Hydrocortisone—asthma	4.43e-05	0.000325	CcSEcCtD
Tapentadol—Vertigo—Triamcinolone—asthma	4.42e-05	0.000324	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	4.41e-05	0.000324	CcSEcCtD
Tapentadol—Syncope—Triamcinolone—asthma	4.41e-05	0.000324	CcSEcCtD
Tapentadol—Vertigo—Methylprednisolone—asthma	4.41e-05	0.000324	CcSEcCtD
Tapentadol—Syncope—Methylprednisolone—asthma	4.4e-05	0.000323	CcSEcCtD
Tapentadol—Connective tissue disorder—Prednisone—asthma	4.38e-05	0.000322	CcSEcCtD
Tapentadol—Nausea—Budesonide—asthma	4.38e-05	0.000321	CcSEcCtD
Tapentadol—Anaphylactic shock—Prednisolone—asthma	4.36e-05	0.00032	CcSEcCtD
Tapentadol—Oedema—Prednisolone—asthma	4.36e-05	0.00032	CcSEcCtD
Tapentadol—Loss of consciousness—Triamcinolone—asthma	4.32e-05	0.000317	CcSEcCtD
Tapentadol—Loss of consciousness—Methylprednisolone—asthma	4.31e-05	0.000317	CcSEcCtD
Tapentadol—Shock—Prednisolone—asthma	4.29e-05	0.000315	CcSEcCtD
Tapentadol—Cough—Triamcinolone—asthma	4.29e-05	0.000315	CcSEcCtD
Tapentadol—Oedema—Hydrocortisone—asthma	4.26e-05	0.000313	CcSEcCtD
Tapentadol—Anaphylactic shock—Hydrocortisone—asthma	4.26e-05	0.000313	CcSEcCtD
Tapentadol—Convulsion—Triamcinolone—asthma	4.26e-05	0.000313	CcSEcCtD
Tapentadol—Tachycardia—Prednisolone—asthma	4.26e-05	0.000313	CcSEcCtD
Tapentadol—Convulsion—Methylprednisolone—asthma	4.25e-05	0.000312	CcSEcCtD
Tapentadol—Infection—Hydrocortisone—asthma	4.23e-05	0.000311	CcSEcCtD
Tapentadol—Hyperhidrosis—Prednisolone—asthma	4.22e-05	0.00031	CcSEcCtD
Tapentadol—Shock—Hydrocortisone—asthma	4.19e-05	0.000308	CcSEcCtD
Tapentadol—Nervous system disorder—Hydrocortisone—asthma	4.18e-05	0.000307	CcSEcCtD
Tapentadol—Arthralgia—Methylprednisolone—asthma	4.18e-05	0.000307	CcSEcCtD
Tapentadol—Eye disorder—Prednisone—asthma	4.17e-05	0.000306	CcSEcCtD
Tapentadol—Anxiety—Methylprednisolone—asthma	4.16e-05	0.000306	CcSEcCtD
Tapentadol—Tachycardia—Hydrocortisone—asthma	4.16e-05	0.000305	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	4.15e-05	0.000305	CcSEcCtD
Tapentadol—Skin disorder—Hydrocortisone—asthma	4.14e-05	0.000304	CcSEcCtD
Tapentadol—Hyperhidrosis—Hydrocortisone—asthma	4.12e-05	0.000302	CcSEcCtD
Tapentadol—Dry mouth—Triamcinolone—asthma	4.09e-05	0.000301	CcSEcCtD
Tapentadol—Angioedema—Betamethasone—asthma	4.08e-05	0.000299	CcSEcCtD
Tapentadol—Angioedema—Dexamethasone—asthma	4.08e-05	0.000299	CcSEcCtD
Tapentadol—Angiopathy—Prednisone—asthma	4.05e-05	0.000297	CcSEcCtD
Tapentadol—Confusional state—Methylprednisolone—asthma	4.04e-05	0.000296	CcSEcCtD
Tapentadol—Immune system disorder—Prednisone—asthma	4.03e-05	0.000296	CcSEcCtD
Tapentadol—Anaphylactic shock—Triamcinolone—asthma	4.01e-05	0.000295	CcSEcCtD
Tapentadol—Oedema—Triamcinolone—asthma	4.01e-05	0.000295	CcSEcCtD
Tapentadol—Vertigo—Betamethasone—asthma	4.01e-05	0.000294	CcSEcCtD
Tapentadol—Vertigo—Dexamethasone—asthma	4.01e-05	0.000294	CcSEcCtD
Tapentadol—Anaphylactic shock—Methylprednisolone—asthma	4e-05	0.000294	CcSEcCtD
Tapentadol—Syncope—Betamethasone—asthma	4e-05	0.000294	CcSEcCtD
Tapentadol—Syncope—Dexamethasone—asthma	4e-05	0.000294	CcSEcCtD
Tapentadol—Infection—Triamcinolone—asthma	3.99e-05	0.000293	CcSEcCtD
Tapentadol—Hypotension—Hydrocortisone—asthma	3.98e-05	0.000292	CcSEcCtD
Tapentadol—Infection—Methylprednisolone—asthma	3.98e-05	0.000292	CcSEcCtD
Tapentadol—Shock—Triamcinolone—asthma	3.95e-05	0.00029	CcSEcCtD
Tapentadol—Insomnia—Prednisolone—asthma	3.95e-05	0.00029	CcSEcCtD
Tapentadol—Shock—Methylprednisolone—asthma	3.94e-05	0.000289	CcSEcCtD
Tapentadol—Nervous system disorder—Methylprednisolone—asthma	3.93e-05	0.000288	CcSEcCtD
Tapentadol—Loss of consciousness—Betamethasone—asthma	3.92e-05	0.000288	CcSEcCtD
Tapentadol—Loss of consciousness—Dexamethasone—asthma	3.92e-05	0.000288	CcSEcCtD
Tapentadol—Paraesthesia—Prednisolone—asthma	3.92e-05	0.000288	CcSEcCtD
Tapentadol—Tachycardia—Triamcinolone—asthma	3.92e-05	0.000288	CcSEcCtD
Tapentadol—Mental disorder—Prednisone—asthma	3.91e-05	0.000287	CcSEcCtD
Tapentadol—Tachycardia—Methylprednisolone—asthma	3.91e-05	0.000287	CcSEcCtD
Tapentadol—Skin disorder—Methylprednisolone—asthma	3.89e-05	0.000286	CcSEcCtD
Tapentadol—Malnutrition—Prednisone—asthma	3.88e-05	0.000285	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Hydrocortisone—asthma	3.88e-05	0.000285	CcSEcCtD
Tapentadol—Hyperhidrosis—Triamcinolone—asthma	3.88e-05	0.000285	CcSEcCtD
Tapentadol—Hyperhidrosis—Methylprednisolone—asthma	3.87e-05	0.000284	CcSEcCtD
Tapentadol—Convulsion—Dexamethasone—asthma	3.86e-05	0.000284	CcSEcCtD
Tapentadol—Convulsion—Betamethasone—asthma	3.86e-05	0.000284	CcSEcCtD
Tapentadol—Insomnia—Hydrocortisone—asthma	3.85e-05	0.000283	CcSEcCtD
Tapentadol—Paraesthesia—Hydrocortisone—asthma	3.83e-05	0.000281	CcSEcCtD
Tapentadol—Anxiety—Dexamethasone—asthma	3.78e-05	0.000278	CcSEcCtD
Tapentadol—Anxiety—Betamethasone—asthma	3.78e-05	0.000278	CcSEcCtD
Tapentadol—Dyspepsia—Hydrocortisone—asthma	3.75e-05	0.000275	CcSEcCtD
Tapentadol—Hypotension—Methylprednisolone—asthma	3.74e-05	0.000275	CcSEcCtD
Tapentadol—Decreased appetite—Hydrocortisone—asthma	3.7e-05	0.000272	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Hydrocortisone—asthma	3.68e-05	0.00027	CcSEcCtD
Tapentadol—Fatigue—Hydrocortisone—asthma	3.67e-05	0.00027	CcSEcCtD
Tapentadol—Vision blurred—Prednisone—asthma	3.66e-05	0.000269	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Triamcinolone—asthma	3.66e-05	0.000268	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Methylprednisolone—asthma	3.65e-05	0.000268	CcSEcCtD
Tapentadol—Anaphylactic shock—Betamethasone—asthma	3.64e-05	0.000267	CcSEcCtD
Tapentadol—Anaphylactic shock—Dexamethasone—asthma	3.64e-05	0.000267	CcSEcCtD
Tapentadol—Oedema—Dexamethasone—asthma	3.64e-05	0.000267	CcSEcCtD
Tapentadol—Oedema—Betamethasone—asthma	3.64e-05	0.000267	CcSEcCtD
Tapentadol—Insomnia—Triamcinolone—asthma	3.63e-05	0.000266	CcSEcCtD
Tapentadol—Insomnia—Methylprednisolone—asthma	3.62e-05	0.000266	CcSEcCtD
Tapentadol—Infection—Betamethasone—asthma	3.62e-05	0.000266	CcSEcCtD
Tapentadol—Infection—Dexamethasone—asthma	3.62e-05	0.000266	CcSEcCtD
Tapentadol—Paraesthesia—Triamcinolone—asthma	3.6e-05	0.000265	CcSEcCtD
Tapentadol—Feeling abnormal—Prednisolone—asthma	3.6e-05	0.000264	CcSEcCtD
Tapentadol—Paraesthesia—Methylprednisolone—asthma	3.59e-05	0.000264	CcSEcCtD
Tapentadol—Shock—Betamethasone—asthma	3.58e-05	0.000263	CcSEcCtD
Tapentadol—Shock—Dexamethasone—asthma	3.58e-05	0.000263	CcSEcCtD
Tapentadol—Dyspnoea—Triamcinolone—asthma	3.58e-05	0.000263	CcSEcCtD
Tapentadol—Nervous system disorder—Betamethasone—asthma	3.57e-05	0.000262	CcSEcCtD
Tapentadol—Nervous system disorder—Dexamethasone—asthma	3.57e-05	0.000262	CcSEcCtD
Tapentadol—Agitation—Prednisone—asthma	3.57e-05	0.000262	CcSEcCtD
Tapentadol—Tachycardia—Betamethasone—asthma	3.55e-05	0.000261	CcSEcCtD
Tapentadol—Tachycardia—Dexamethasone—asthma	3.55e-05	0.000261	CcSEcCtD
Tapentadol—Angioedema—Prednisone—asthma	3.55e-05	0.000261	CcSEcCtD
Tapentadol—Dyspepsia—Triamcinolone—asthma	3.53e-05	0.000259	CcSEcCtD
Tapentadol—Dyspepsia—Methylprednisolone—asthma	3.52e-05	0.000259	CcSEcCtD
Tapentadol—Hyperhidrosis—Dexamethasone—asthma	3.52e-05	0.000258	CcSEcCtD
Tapentadol—Hyperhidrosis—Betamethasone—asthma	3.52e-05	0.000258	CcSEcCtD
Tapentadol—Feeling abnormal—Hydrocortisone—asthma	3.51e-05	0.000258	CcSEcCtD
Tapentadol—Vertigo—Prednisone—asthma	3.49e-05	0.000256	CcSEcCtD
Tapentadol—Syncope—Prednisone—asthma	3.48e-05	0.000256	CcSEcCtD
Tapentadol—Urticaria—Prednisolone—asthma	3.47e-05	0.000254	CcSEcCtD
Tapentadol—Fatigue—Triamcinolone—asthma	3.46e-05	0.000254	CcSEcCtD
Tapentadol—Fatigue—Methylprednisolone—asthma	3.45e-05	0.000253	CcSEcCtD
Tapentadol—Loss of consciousness—Prednisone—asthma	3.41e-05	0.000251	CcSEcCtD
Tapentadol—Hypotension—Dexamethasone—asthma	3.4e-05	0.00025	CcSEcCtD
Tapentadol—Hypotension—Betamethasone—asthma	3.4e-05	0.00025	CcSEcCtD
Tapentadol—Urticaria—Hydrocortisone—asthma	3.38e-05	0.000249	CcSEcCtD
Tapentadol—Convulsion—Prednisone—asthma	3.37e-05	0.000247	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Dexamethasone—asthma	3.32e-05	0.000244	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Betamethasone—asthma	3.32e-05	0.000244	CcSEcCtD
Tapentadol—Arthralgia—Prednisone—asthma	3.31e-05	0.000243	CcSEcCtD
Tapentadol—Feeling abnormal—Triamcinolone—asthma	3.31e-05	0.000243	CcSEcCtD
Tapentadol—Feeling abnormal—Methylprednisolone—asthma	3.3e-05	0.000242	CcSEcCtD
Tapentadol—Anxiety—Prednisone—asthma	3.3e-05	0.000242	CcSEcCtD
Tapentadol—Insomnia—Betamethasone—asthma	3.29e-05	0.000242	CcSEcCtD
Tapentadol—Insomnia—Dexamethasone—asthma	3.29e-05	0.000242	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	3.28e-05	0.000241	CcSEcCtD
Tapentadol—Paraesthesia—Dexamethasone—asthma	3.27e-05	0.00024	CcSEcCtD
Tapentadol—Paraesthesia—Betamethasone—asthma	3.27e-05	0.00024	CcSEcCtD
Tapentadol—Hypersensitivity—Prednisolone—asthma	3.21e-05	0.000236	CcSEcCtD
Tapentadol—Dyspepsia—Dexamethasone—asthma	3.2e-05	0.000235	CcSEcCtD
Tapentadol—Dyspepsia—Betamethasone—asthma	3.2e-05	0.000235	CcSEcCtD
Tapentadol—Urticaria—Triamcinolone—asthma	3.19e-05	0.000234	CcSEcCtD
Tapentadol—Urticaria—Methylprednisolone—asthma	3.18e-05	0.000234	CcSEcCtD
Tapentadol—Oedema—Prednisone—asthma	3.17e-05	0.000233	CcSEcCtD
Tapentadol—Anaphylactic shock—Prednisone—asthma	3.17e-05	0.000233	CcSEcCtD
Tapentadol—Decreased appetite—Dexamethasone—asthma	3.16e-05	0.000232	CcSEcCtD
Tapentadol—Decreased appetite—Betamethasone—asthma	3.16e-05	0.000232	CcSEcCtD
Tapentadol—Infection—Prednisone—asthma	3.15e-05	0.000231	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Dexamethasone—asthma	3.14e-05	0.000231	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Betamethasone—asthma	3.14e-05	0.000231	CcSEcCtD
Tapentadol—Hypersensitivity—Hydrocortisone—asthma	3.14e-05	0.000231	CcSEcCtD
Tapentadol—Fatigue—Dexamethasone—asthma	3.14e-05	0.00023	CcSEcCtD
Tapentadol—Fatigue—Betamethasone—asthma	3.14e-05	0.00023	CcSEcCtD
Tapentadol—Shock—Prednisone—asthma	3.12e-05	0.000229	CcSEcCtD
Tapentadol—Nervous system disorder—Prednisone—asthma	3.11e-05	0.000228	CcSEcCtD
Tapentadol—Tachycardia—Prednisone—asthma	3.09e-05	0.000227	CcSEcCtD
Tapentadol—Skin disorder—Prednisone—asthma	3.08e-05	0.000226	CcSEcCtD
Tapentadol—Hyperhidrosis—Prednisone—asthma	3.06e-05	0.000225	CcSEcCtD
Tapentadol—Asthenia—Hydrocortisone—asthma	3.06e-05	0.000224	CcSEcCtD
Tapentadol—Pruritus—Hydrocortisone—asthma	3.01e-05	0.000221	CcSEcCtD
Tapentadol—Feeling abnormal—Betamethasone—asthma	3e-05	0.00022	CcSEcCtD
Tapentadol—Feeling abnormal—Dexamethasone—asthma	3e-05	0.00022	CcSEcCtD
Tapentadol—Hypersensitivity—Triamcinolone—asthma	2.96e-05	0.000217	CcSEcCtD
Tapentadol—Hypersensitivity—Methylprednisolone—asthma	2.95e-05	0.000217	CcSEcCtD
Tapentadol—Diarrhoea—Hydrocortisone—asthma	2.92e-05	0.000214	CcSEcCtD
Tapentadol—Urticaria—Betamethasone—asthma	2.89e-05	0.000212	CcSEcCtD
Tapentadol—Urticaria—Dexamethasone—asthma	2.89e-05	0.000212	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Prednisone—asthma	2.89e-05	0.000212	CcSEcCtD
Tapentadol—Dizziness—Prednisolone—asthma	2.88e-05	0.000212	CcSEcCtD
Tapentadol—Asthenia—Triamcinolone—asthma	2.88e-05	0.000211	CcSEcCtD
Tapentadol—Asthenia—Methylprednisolone—asthma	2.87e-05	0.000211	CcSEcCtD
Tapentadol—Insomnia—Prednisone—asthma	2.87e-05	0.000211	CcSEcCtD
Tapentadol—Paraesthesia—Prednisone—asthma	2.85e-05	0.000209	CcSEcCtD
Tapentadol—Pruritus—Triamcinolone—asthma	2.84e-05	0.000208	CcSEcCtD
Tapentadol—Pruritus—Methylprednisolone—asthma	2.83e-05	0.000208	CcSEcCtD
Tapentadol—Dizziness—Hydrocortisone—asthma	2.82e-05	0.000207	CcSEcCtD
Tapentadol—Dyspepsia—Prednisone—asthma	2.79e-05	0.000205	CcSEcCtD
Tapentadol—Decreased appetite—Prednisone—asthma	2.76e-05	0.000202	CcSEcCtD
Tapentadol—Rash—Prednisolone—asthma	2.75e-05	0.000202	CcSEcCtD
Tapentadol—Dermatitis—Prednisolone—asthma	2.75e-05	0.000202	CcSEcCtD
Tapentadol—Diarrhoea—Methylprednisolone—asthma	2.74e-05	0.000201	CcSEcCtD
Tapentadol—Fatigue—Prednisone—asthma	2.73e-05	0.000201	CcSEcCtD
Tapentadol—Headache—Prednisolone—asthma	2.73e-05	0.000201	CcSEcCtD
Tapentadol—Constipation—Prednisone—asthma	2.71e-05	0.000199	CcSEcCtD
Tapentadol—Vomiting—Hydrocortisone—asthma	2.71e-05	0.000199	CcSEcCtD
Tapentadol—Rash—Hydrocortisone—asthma	2.69e-05	0.000197	CcSEcCtD
Tapentadol—Dermatitis—Hydrocortisone—asthma	2.68e-05	0.000197	CcSEcCtD
Tapentadol—Headache—Hydrocortisone—asthma	2.67e-05	0.000196	CcSEcCtD
Tapentadol—Dizziness—Triamcinolone—asthma	2.65e-05	0.000195	CcSEcCtD
Tapentadol—Dizziness—Methylprednisolone—asthma	2.65e-05	0.000194	CcSEcCtD
Tapentadol—Feeling abnormal—Prednisone—asthma	2.61e-05	0.000192	CcSEcCtD
Tapentadol—Asthenia—Betamethasone—asthma	2.61e-05	0.000192	CcSEcCtD
Tapentadol—Asthenia—Dexamethasone—asthma	2.61e-05	0.000192	CcSEcCtD
Tapentadol—Nausea—Prednisolone—asthma	2.59e-05	0.00019	CcSEcCtD
Tapentadol—Pruritus—Betamethasone—asthma	2.58e-05	0.000189	CcSEcCtD
Tapentadol—Pruritus—Dexamethasone—asthma	2.58e-05	0.000189	CcSEcCtD
Tapentadol—Vomiting—Triamcinolone—asthma	2.55e-05	0.000187	CcSEcCtD
Tapentadol—Vomiting—Methylprednisolone—asthma	2.55e-05	0.000187	CcSEcCtD
Tapentadol—Nausea—Hydrocortisone—asthma	2.53e-05	0.000186	CcSEcCtD
Tapentadol—Rash—Triamcinolone—asthma	2.53e-05	0.000186	CcSEcCtD
Tapentadol—Dermatitis—Triamcinolone—asthma	2.53e-05	0.000186	CcSEcCtD
Tapentadol—Rash—Methylprednisolone—asthma	2.52e-05	0.000185	CcSEcCtD
Tapentadol—Dermatitis—Methylprednisolone—asthma	2.52e-05	0.000185	CcSEcCtD
Tapentadol—Urticaria—Prednisone—asthma	2.52e-05	0.000185	CcSEcCtD
Tapentadol—Headache—Triamcinolone—asthma	2.51e-05	0.000185	CcSEcCtD
Tapentadol—Headache—Methylprednisolone—asthma	2.51e-05	0.000184	CcSEcCtD
Tapentadol—Diarrhoea—Betamethasone—asthma	2.49e-05	0.000183	CcSEcCtD
Tapentadol—Diarrhoea—Dexamethasone—asthma	2.49e-05	0.000183	CcSEcCtD
Tapentadol—Dizziness—Betamethasone—asthma	2.41e-05	0.000177	CcSEcCtD
Tapentadol—Dizziness—Dexamethasone—asthma	2.41e-05	0.000177	CcSEcCtD
Tapentadol—Nausea—Triamcinolone—asthma	2.38e-05	0.000175	CcSEcCtD
Tapentadol—Nausea—Methylprednisolone—asthma	2.38e-05	0.000175	CcSEcCtD
Tapentadol—Hypersensitivity—Prednisone—asthma	2.34e-05	0.000172	CcSEcCtD
Tapentadol—Vomiting—Dexamethasone—asthma	2.31e-05	0.00017	CcSEcCtD
Tapentadol—Vomiting—Betamethasone—asthma	2.31e-05	0.00017	CcSEcCtD
Tapentadol—Rash—Betamethasone—asthma	2.3e-05	0.000169	CcSEcCtD
Tapentadol—Rash—Dexamethasone—asthma	2.3e-05	0.000169	CcSEcCtD
Tapentadol—Dermatitis—Dexamethasone—asthma	2.29e-05	0.000168	CcSEcCtD
Tapentadol—Dermatitis—Betamethasone—asthma	2.29e-05	0.000168	CcSEcCtD
Tapentadol—Headache—Dexamethasone—asthma	2.28e-05	0.000167	CcSEcCtD
Tapentadol—Headache—Betamethasone—asthma	2.28e-05	0.000167	CcSEcCtD
Tapentadol—Asthenia—Prednisone—asthma	2.27e-05	0.000167	CcSEcCtD
Tapentadol—Pruritus—Prednisone—asthma	2.24e-05	0.000165	CcSEcCtD
Tapentadol—Diarrhoea—Prednisone—asthma	2.17e-05	0.000159	CcSEcCtD
Tapentadol—Nausea—Betamethasone—asthma	2.16e-05	0.000159	CcSEcCtD
Tapentadol—Nausea—Dexamethasone—asthma	2.16e-05	0.000159	CcSEcCtD
Tapentadol—Dizziness—Prednisone—asthma	2.1e-05	0.000154	CcSEcCtD
Tapentadol—Vomiting—Prednisone—asthma	2.02e-05	0.000148	CcSEcCtD
Tapentadol—Rash—Prednisone—asthma	2e-05	0.000147	CcSEcCtD
Tapentadol—Dermatitis—Prednisone—asthma	2e-05	0.000147	CcSEcCtD
Tapentadol—Headache—Prednisone—asthma	1.99e-05	0.000146	CcSEcCtD
Tapentadol—Nausea—Prednisone—asthma	1.88e-05	0.000138	CcSEcCtD
Tapentadol—OPRM1—Signaling Pathways—AGTR2—asthma	9.09e-06	0.000139	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ARG1—asthma	9.07e-06	0.000138	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—asthma	9.07e-06	0.000138	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NTRK1—asthma	9.04e-06	0.000138	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALDH7A1—asthma	8.99e-06	0.000137	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCR5—asthma	8.96e-06	0.000137	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ADRB2—asthma	8.95e-06	0.000136	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ADCY2—asthma	8.85e-06	0.000135	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL2RA—asthma	8.84e-06	0.000135	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL3—asthma	8.82e-06	0.000134	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PLA2G4A—asthma	8.81e-06	0.000134	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GSTM1—asthma	8.81e-06	0.000134	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—C3—asthma	8.76e-06	0.000134	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EDNRB—asthma	8.7e-06	0.000133	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ARG2—asthma	8.62e-06	0.000131	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NPS—asthma	8.61e-06	0.000131	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TAC1—asthma	8.61e-06	0.000131	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ITPR1—asthma	8.46e-06	0.000129	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCR3—asthma	8.45e-06	0.000129	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—RHOA—asthma	8.33e-06	0.000127	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—KNG1—asthma	8.32e-06	0.000127	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—POMC—asthma	8.29e-06	0.000126	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALDH7A1—asthma	8.27e-06	0.000126	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AGTR1—asthma	8.27e-06	0.000126	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALDH7A1—asthma	8.2e-06	0.000125	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CYBA—asthma	8.18e-06	0.000125	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PPP2CA—asthma	8.12e-06	0.000124	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCL2—asthma	8.11e-06	0.000124	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL6R—asthma	8.09e-06	0.000123	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCL10—asthma	8.08e-06	0.000123	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CD86—asthma	8.06e-06	0.000123	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CXCL8—asthma	8.05e-06	0.000123	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—RHOA—asthma	8.04e-06	0.000123	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PARP1—asthma	8.01e-06	0.000122	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL5—asthma	8.01e-06	0.000122	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—EDN1—asthma	7.99e-06	0.000122	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL5—asthma	7.93e-06	0.000121	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ARG2—asthma	7.93e-06	0.000121	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NTRK1—asthma	7.93e-06	0.000121	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—asthma	7.91e-06	0.000121	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PLA2G4A—asthma	7.9e-06	0.00012	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ARG2—asthma	7.86e-06	0.00012	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ADRB2—asthma	7.84e-06	0.00012	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CSF2—asthma	7.81e-06	0.000119	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GSTP1—asthma	7.79e-06	0.000119	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—BDKRB2—asthma	7.73e-06	0.000118	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—POMC—asthma	7.72e-06	0.000118	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—IL2—asthma	7.7e-06	0.000117	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—HMOX1—asthma	7.69e-06	0.000117	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ITPR1—asthma	7.67e-06	0.000117	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SMAD3—asthma	7.61e-06	0.000116	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CAT—asthma	7.58e-06	0.000116	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	7.56e-06	0.000115	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ADCY2—asthma	7.48e-06	0.000114	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL3—asthma	7.45e-06	0.000114	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ITPR1—asthma	7.42e-06	0.000113	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CXCL8—asthma	7.31e-06	0.000112	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—RHOA—asthma	7.3e-06	0.000111	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PPP2CA—asthma	7.28e-06	0.000111	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PLA2G4A—asthma	7.16e-06	0.000109	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GSTM1—asthma	7.16e-06	0.000109	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCR5—asthma	7.15e-06	0.000109	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALOX15—asthma	7.14e-06	0.000109	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALOX5AP—asthma	7.14e-06	0.000109	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CD86—asthma	7.07e-06	0.000108	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CXCL8—asthma	7.06e-06	0.000108	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL2RA—asthma	7.04e-06	0.000107	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—KNG1—asthma	7.03e-06	0.000107	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—EDN1—asthma	7.01e-06	0.000107	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—POMC—asthma	7.01e-06	0.000107	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL2—asthma	6.99e-06	0.000107	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AGTR1—asthma	6.99e-06	0.000107	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—C3—asthma	6.98e-06	0.000106	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL5—asthma	6.96e-06	0.000106	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PLA2G4A—asthma	6.93e-06	0.000106	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	6.89e-06	0.000105	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCL2—asthma	6.86e-06	0.000105	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CSF2—asthma	6.85e-06	0.000104	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6R—asthma	6.83e-06	0.000104	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCL10—asthma	6.83e-06	0.000104	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CHAT—asthma	6.82e-06	0.000104	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—RHOA—asthma	6.8e-06	0.000104	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PDGFB—asthma	6.8e-06	0.000104	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—IL2—asthma	6.75e-06	0.000103	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NTRK1—asthma	6.7e-06	0.000102	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SMAD3—asthma	6.67e-06	0.000102	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ADRB2—asthma	6.63e-06	0.000101	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PPP2CA—asthma	6.6e-06	0.000101	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALOX5AP—asthma	6.57e-06	0.0001	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALOX15—asthma	6.57e-06	0.0001	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALOX15—asthma	6.51e-06	9.93e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALOX5AP—asthma	6.51e-06	9.93e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—LEP—asthma	6.5e-06	9.91e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CXCL8—asthma	6.41e-06	9.78e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PPP2CA—asthma	6.38e-06	9.73e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ITPR1—asthma	6.27e-06	9.56e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CHAT—asthma	6.27e-06	9.56e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCR5—asthma	6.27e-06	9.56e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—POMC—asthma	6.23e-06	9.5e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CHAT—asthma	6.21e-06	9.48e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL2RA—asthma	6.18e-06	9.42e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—RHOA—asthma	6.17e-06	9.41e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—FN1—asthma	6.13e-06	9.35e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL2—asthma	6.13e-06	9.35e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—C3—asthma	6.12e-06	9.34e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALOX5—asthma	6.07e-06	9.26e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CD86—asthma	5.97e-06	9.11e-05	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CXCL8—asthma	5.97e-06	9.1e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PDGFB—asthma	5.96e-06	9.09e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EDN1—asthma	5.92e-06	9.03e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL5—asthma	5.88e-06	8.96e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PLA2G4A—asthma	5.86e-06	8.93e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CARM1—asthma	5.79e-06	8.84e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CSF2—asthma	5.79e-06	8.83e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—DCN—asthma	5.71e-06	8.71e-05	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—IL2—asthma	5.7e-06	8.7e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—LEP—asthma	5.7e-06	8.69e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ALB—asthma	5.68e-06	8.66e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SMAD3—asthma	5.64e-06	8.6e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALOX5—asthma	5.59e-06	8.52e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—POMC—asthma	5.58e-06	8.52e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALDH2—asthma	5.56e-06	8.47e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALOX5—asthma	5.54e-06	8.45e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL2—asthma	5.46e-06	8.33e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6R—asthma	5.45e-06	8.31e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—NOS3—asthma	5.43e-06	8.28e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCL8—asthma	5.42e-06	8.26e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PPP2CA—asthma	5.39e-06	8.22e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—FN1—asthma	5.38e-06	8.2e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—EGFR—asthma	5.35e-06	8.15e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—asthma	5.34e-06	8.15e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CARM1—asthma	5.33e-06	8.13e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCR5—asthma	5.3e-06	8.08e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GSTT1—asthma	5.28e-06	8.06e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CARM1—asthma	5.28e-06	8.06e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—DCN—asthma	5.25e-06	8.01e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL2RA—asthma	5.22e-06	7.96e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—DCN—asthma	5.21e-06	7.94e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL2—asthma	5.18e-06	7.9e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—C3—asthma	5.18e-06	7.89e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALDH2—asthma	5.11e-06	7.79e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SERPINE1—asthma	5.1e-06	7.78e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALDH2—asthma	5.07e-06	7.72e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—POMC—asthma	5.06e-06	7.72e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PDGFB—asthma	5.04e-06	7.68e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTGS2—asthma	4.97e-06	7.58e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RHOA—asthma	4.92e-06	7.5e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—POMC—asthma	4.9e-06	7.47e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	4.87e-06	7.43e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NOS3—asthma	4.87e-06	7.43e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—asthma	4.87e-06	7.43e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GSTT1—asthma	4.86e-06	7.41e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GSTT1—asthma	4.82e-06	7.35e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—LEP—asthma	4.82e-06	7.35e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL2—asthma	4.79e-06	7.31e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6R—asthma	4.78e-06	7.28e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—EGFR—asthma	4.69e-06	7.15e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ALB—asthma	4.61e-06	7.04e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—FN1—asthma	4.54e-06	6.93e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SERPINE1—asthma	4.47e-06	6.82e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	4.44e-06	6.77e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—NOS3—asthma	4.41e-06	6.73e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NQO1—asthma	4.39e-06	6.7e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTEN—asthma	4.33e-06	6.61e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCL8—asthma	4.32e-06	6.59e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RHOA—asthma	4.32e-06	6.58e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ADCY2—asthma	4.3e-06	6.55e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NOS3—asthma	4.27e-06	6.51e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—asthma	4.26e-06	6.5e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—POMC—asthma	4.14e-06	6.31e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL2—asthma	4.13e-06	6.3e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL6—asthma	4.11e-06	6.26e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL2—asthma	4.05e-06	6.18e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NQO1—asthma	4.04e-06	6.16e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6R—asthma	4.04e-06	6.16e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTGS2—asthma	4.04e-06	6.16e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NQO1—asthma	4e-06	6.11e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—EGFR—asthma	3.96e-06	6.04e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ADCY2—asthma	3.95e-06	6.03e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ADCY2—asthma	3.92e-06	5.98e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MMP9—asthma	3.91e-06	5.96e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	3.89e-06	5.92e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PTEN—asthma	3.88e-06	5.92e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCL8—asthma	3.79e-06	5.78e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SERPINE1—asthma	3.78e-06	5.77e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—asthma	3.72e-06	5.67e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GSTP1—asthma	3.66e-06	5.59e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RHOA—asthma	3.65e-06	5.56e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL2—asthma	3.62e-06	5.52e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—HMOX1—asthma	3.61e-06	5.51e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOS3—asthma	3.61e-06	5.5e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ITPR1—asthma	3.6e-06	5.5e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL6—asthma	3.6e-06	5.49e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CAT—asthma	3.56e-06	5.44e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTEN—asthma	3.52e-06	5.37e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—VEGFA—asthma	3.51e-06	5.35e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—STAT3—asthma	3.47e-06	5.3e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MMP9—asthma	3.43e-06	5.23e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PTEN—asthma	3.41e-06	5.19e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	3.39e-06	5.17e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GSTP1—asthma	3.37e-06	5.14e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GSTM1—asthma	3.37e-06	5.13e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PLA2G4A—asthma	3.37e-06	5.13e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GSTP1—asthma	3.34e-06	5.09e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—HMOX1—asthma	3.32e-06	5.07e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ITPR1—asthma	3.32e-06	5.06e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—HMOX1—asthma	3.29e-06	5.02e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ITPR1—asthma	3.29e-06	5.01e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CAT—asthma	3.28e-06	5e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CAT—asthma	3.25e-06	4.96e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TGFB1—asthma	3.22e-06	4.91e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCL8—asthma	3.2e-06	4.88e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—EGFR—asthma	3.16e-06	4.82e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPP2CA—asthma	3.1e-06	4.73e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PLA2G4A—asthma	3.1e-06	4.72e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GSTM1—asthma	3.1e-06	4.72e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—VEGFA—asthma	3.08e-06	4.69e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PLA2G4A—asthma	3.07e-06	4.68e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GSTM1—asthma	3.07e-06	4.68e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL2—asthma	3.06e-06	4.67e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—STAT3—asthma	3.05e-06	4.65e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6—asthma	3.04e-06	4.64e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MMP9—asthma	2.9e-06	4.42e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PTEN—asthma	2.88e-06	4.39e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPP2CA—asthma	2.85e-06	4.35e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPP2CA—asthma	2.83e-06	4.31e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TGFB1—asthma	2.82e-06	4.31e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—EGFR—asthma	2.77e-06	4.22e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—VEGFA—asthma	2.6e-06	3.97e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—STAT3—asthma	2.57e-06	3.93e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6—asthma	2.43e-06	3.7e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TGFB1—asthma	2.39e-06	3.64e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—POMC—asthma	2.38e-06	3.63e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EGFR—asthma	2.34e-06	3.57e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—POMC—asthma	2.19e-06	3.34e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—POMC—asthma	2.17e-06	3.31e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALB—asthma	2.17e-06	3.31e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6—asthma	2.13e-06	3.25e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NOS3—asthma	2.07e-06	3.16e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALB—asthma	1.99e-06	3.04e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALB—asthma	1.98e-06	3.02e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NOS3—asthma	1.91e-06	2.91e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTGS2—asthma	1.9e-06	2.89e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NOS3—asthma	1.89e-06	2.88e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6—asthma	1.8e-06	2.74e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTGS2—asthma	1.75e-06	2.66e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTGS2—asthma	1.73e-06	2.64e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTEN—asthma	1.65e-06	2.52e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTEN—asthma	1.52e-06	2.32e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTEN—asthma	1.51e-06	2.3e-05	CbGpPWpGaD
